Exclusive: Drug firm Ikaria on the block for more than $2 billion - sources

Ikaria Inc, a private equity and venture capital-backed company whose products are focused on critically ill patients, is exploring a sale that it hopes could value it at more than $2 billion, three people ...



via Business News http://finance.yahoo.com/news/exclusive-drug-firm-ikaria-block-070209940.html